Ocanat 10mg Tablet contains Obeticholic acid 10mg, a potent farnesoid X receptor (FXR) agonist used primarily in the treatment of certain liver disorders. Obeticholic acid acts by modulating bile acid synthesis and transport, thereby reducing hepatic inflammation and fibrosis. It is indicated for the management of primary biliary cholangitis (PBC) in adult patients who have an inadequate response to or are intolerant of ursodeoxycholic acid (UDCA). By activating FXR, Ocanat helps to decrease the accumulation of toxic bile acids in the liver, improving liver function and slowing disease progression. The recommended dosage and administration should be strictly followed as per clinical guidelines, with regular monitoring of liver function tests and lipid profiles due to potential side effects such as pruritus and elevated cholesterol levels. Ocanat is contraindicated in patients with complete biliary obstruction and should be used with caution in those with advanced liver disease. Adverse reactions may include fatigue, abdominal discomfort, and headache. Patient adherence and periodic evaluation are essential to optimize therapeutic outcomes and minimize risks. Ocanat 10mg Tablet should be prescribed by a healthcare professional experienced in managing chronic liver conditions.